Health ❯ Biotechnology

Drug Development

Clinical Trials Gene Therapy Protein Applications Vaccine Design Regulatory Affairs Antibodies Weight Loss Drugs Cancer Treatment Alzheimer's Drugs Press Releases Biosimilars Company Closures Protein Therapeutics AI in Healthcare Clinical Efficacy Neurodegenerative Disorders Cancer Research Viral Hepatitis Cardiovascular Drugs Obesity Treatments Clinical Testing Research Investments Therapeutics Molecular Transport

Nuclera Extends Series C to $87 Million to Accelerate Full-Format Antibody Workflows

The company targets AI-ready, standardized protein datasets by building end-to-end antibody capabilities into its benchtop eProtein Discovery platform.

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Prolynx Raises $70 Million to Advance Ultra-Long-Acting Obesity Drugs

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Lilly and Breakthrough to Open Gateway Labs Biotech Incubator at 2300 Market in Philadelphia

FDA Flags Possible License Revocation for Sarepta’s Elevidys